SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001079973-24-000812
Filing Date
2024-05-24
Accepted
2024-05-24 16:30:20
Documents
14
Period of Report
2024-05-20
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K scpx_8k.htm   iXBRL 8-K 31587
  Complete submission text file 0001079973-24-000812.txt   249062

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE scpx-20240520.xsd EX-101.SCH 3549
3 XBRL DEFINITION FILE scpx-20240520_def.xml EX-101.DEF 26579
4 XBRL LABEL FILE scpx-20240520_lab.xml EX-101.LAB 36527
5 XBRL PRESENTATION FILE scpx-20240520_pre.xml EX-101.PRE 25203
17 EXTRACTED XBRL INSTANCE DOCUMENT scpx_8k_htm.xml XML 5514
Mailing Address 627 DAVIS DRIVE SUITE 300 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 300 MORRISVILLE NC 27560 919-240-7133
Scorpius Holdings, Inc. (Filer) CIK: 0001476963 (see all company filings)

IRS No.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35994 | Film No.: 24984857
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)